' The cytotoxicity and antitumour activity of the isoquinoline alkaloid berberine was studied in-vitro and in-vivo.
Isoquinoline alkaloids, such as berberine (Figure I) , are an important class of natural products with biological activity (Suffness & Cordell 1985; Bhakuni & Jain 1986) . Berberine has been shown to be a constituent of many medicinal preparations in India and China and was initially isolated from a Chinese herbal medicine and used as an antibiotic. Its antibacterial action has also been demonstrated (Hahn & Ciak 1975; Ghosh et al 1990) .
The effects of berberine on calcium channels (Zhou et al 1995) , platelet aggregation and aggregation of DNA (Matsumato et al 1994) have been reported. Recently berberine has been shown to induce apoptosis (Kuo et al 1995) and induce differentiation of human teratocarcinoma cells (Chang et al 1990) . Berberine has also heen shown to down regulate c-ki-ras-? cellular oncogenes (Chang el al 1990) . Because of its ability to produce DNA adducts and induce apoptosis, berberine may be useful in cancer treatment and may induce tumour cell death in experimental animals. In this study we investigated the antitumour activity of berberine in
Materials and Methods

Animals
Swiss albino mice, 20-25 g, were housed in ventilated cages. They were given pelleted mice food (Lipton India Ltd, Bangalore) and had free access to water.
Cells
Dalton's lymphoma ascites cells (DLA) were propagated in Swiss albino mice by injecting 10' cells intraperitoneally. L929 cells were procured from the National Centre for Cell Science, Pune, and maintained by subculturing in Minimum Essential Medium (MEM) (Himediii, Ro~nhay) conlaining 10% goat serum. (3-(4.5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Spectrochem, Bombay. Berberine hydrochloride was a gift from Dr Rajpal, Kisalaya Herbals Ltd, Indore. ascites and solid tumour models. We also studied the synergistic activity of berberine in combination Determination of in-vitro cytotoxicity of berberine with other treatments such as chemotherapeutic hydrochloride agents, hypedermia and radiation to determine if Shofi-term in-vitro cytotoxicity studies were carried it can act as an adjuvant response modifier. out using DLA tumour cells (Kuttan et al 1985) .
Berberine hydrochloride was dissolved in hot water Correspondence: R. Kunan. Amah Cancer Research Center, and (Io0-Ioo0 Pg mL-') Amala Nagar. Thrissur hXO 551, India.
were incubated with tumour cells (10') suspended in phosphate-buffered saline (PBS, pH 7.2) r nd cytotoxicity was determined after 3 h using the trypan blue exclusion method.
Determination of cytotoxicity of berberine hydrochloride in tissue culture
Cytotoxicity of berberine hydrochloride in culture was determined using L929 cells. Cells (lo4) were plated in 96-well flat-bottomed titre plates .ind maintained with MEM containing 10% goat senlm. Various concentrations of berberine hydrochlolide ( 1 0 -1 0 0~g m~-' ) were added to the wells md incubated for 72 h. MTT (5%, 20 pL) was added to the wells 4 h before the end of incubation. Medium and reagents were aspirated, 98% dimethylsulphoxide (DMSO) was added and after shaking for 15 min, the absorbance was measured at 545 nm with a reference wavelength of 630nm using an Elisa plate reader (Awareness Technology Iric.). The percentage cytotoxicity was calculated and compared with untreated controls.
Uetertniriutiorr o/' ~rrriluntour activity o/' l~erberine hydrochloride Ascites tumour. DLA cells were aspirated from the peritoneal cavity of mice and washed with I'BS. Mice were inoculated with a 0.1-mL PBS containing 10' cells. The mice were divided into four groups (6 mice per group). Group I acled at an untreated control. Groups 2, 3 and 4 were given berberine hydrochloride (10, 2.5 and O.5mg kg-', i.p, respectively) everyday for 10 days. In another set of experiments, four groups of mice (6 mice per group) were used to determint: the oral efficacy of berberine. Group 1 was the corltrol. Groups 2, 3 and 4 received berberine hydrochloride (25, 5 and 1 mgkg-I, respectively) dissolved in hot water for 10 days. The pattern of death d i e to tumour burden was noted and the percentage increase in life span was calculated (Kuttan et al 1988) .
Solid tumour. DLA cells (10') were injected intramuscularly into the right hind limb of mice. Mice were divided into seven groups (6 mice per group). Group 1 served as the untreated control. Groups 2, 3 and 4 received intraperitoneal administration of berberine hydrochloride and groups 5 , 6 and 7 were treated with berberine hydrochloride (10, 2.5 and 0.5mgkg-', p.o., respectively) for 10 days. The tumour diameter was measured on every third day and tumour volume was calculated by the formula:
where V is the volume, rl and r2 are the radius of the tumour. The results were compared with the untreated control.
Arrtitumo~lr activity of herberine hydrochloride in combination with other treatments Berherine and cyclophosphomide. DLA cells were aspirated from tumour-bearing mice and 0.1 mL containing lo6 cells was injected intramuscularly into the right hind limb of Swiss albino mice. Four groups (6 mice per group) were used. Group 1 acted as the control, group 2 received cyclophosphomide (15mgkp-', i.p), group 3 received berberine (25 mg kg-, p.0.) and group 4 received both cyclophosphomide and berberine. Drug administration continued for 10 consecutive days. The diameter of the tumour was measured and the volume was determined.
Berherine and radiation. Mice were divided into I'our groups (6 mice per group) and tumour cells (lo6) were injected intramuscularly into the right hind limb. Group 1 acted as the control. Group 2 was subjected to irradiation (600 rads) using a CO" gamma source (Theratron 780, Telecobalt unit, Atomic energy Canada Ltd). Group 3 received berberine hydrochloride (25mgkg-I, p.0.) and group 4 received both radiation and berberine. Drug administration continued for 10 consecutive days. The diameter of the tumour was measured on every third day and the volume was determined.
Berberine and hypertherrnia. Tumour cells (10') were injected into the right hind limb of 4 groups of mice (20-25 g). Group 1 acted as the untreated control. Group 2 received whole body hyperthermia on day 7 after tumour inoculation by subjecting the mice to whole body heating (43'C for 30 min), group 3 received berberine hydrochloride (25mgkg-I, p a . ) from day 7 -17. and group 4 received both berberine and hyperthennia. The diameter of the tumour was measured and tumour volume was determined every third day.
Results
Berberine hydrochloride was cytotoxic (44%) to DLA tumour cells only at a concentration of I mg m~. -' or greater in-vitrc). At lower concentrations, it produccd a dose-dependent cytotoxic effect to DLA cells. Berberine hydrochloride was cytotoxic to L929 cells in cultur~ at much lower concentration (Table I ). The concentration of berberine hydrochloride needed to produce 50% cytotoxicity to L929 cells in culture was approximately 40 pg m~-' .
Mice treated with berberine hydrochloride had a significantly increased life span ( P < 0.001). The life span of mice receiving IOmgkg-' berberine hydrochloride intrapentonen& for LO consecutive days was increased by 32%. Mice treated with 2.5 and 0.5 mg kg-' berberine hydrochloride intraperitoneally had an increase in life span of 12 and 15%, but this was not significant (Table 2) . Oral administration produced a lesser increase in the life span of ascites tumour-bearing mice and even at 25mgkg-' it produced only a 5% increase in life span. The solid tumour volume of mice treated with berberine hydrochloride intraperitoneally was significantly decreased in mice treated with 10mgkg-' for 10 days ( P < 0.01). At day 30 the tumour volume of the control mice was 5.5cm3 while that of mice treated with IOmgkg-' berberine hydrochloride was 0.86cm3. In mice treated with 2.5 and O.5rngkg-l berberine hydrochloride, the tumour volume was reduced to 1.81 and 2.12cm3, respectively (Figure 2 ). Oral administration of berberine hydrochloride also reduced the tumour volume significantly ( P < 0.001). The tumour volume of untreated control mice was 5.06 cm7 at day 30, while that of mice treated with 25 mg kg-' berberine hydrochloride was I .5 cm'. A dose-dependent reduction waq found in the remaining groups (Figure 2 ).
Synergistic effect of berberine hydrochloride in conjunction with other treatments
Cyclophosphomide. The tumour volume of untreated control mice was 5.1 cm' at day 30 and this was reduced to 1.42cm3 (72%) by oral administration of berberine hydrochloride. In mice treated Radiation. The tumour volume of untreated control mice was 5 em2 at day 30. In the berberine hydrochloride-treated group, the tumour volume was reduced by 60% to 2cm3. In the radiation-mated group, thc lulnour volumc was 2.5cn1' which was 50% lower than the control. There was a synergistic reduction in tumour volume, when berb-rine hydrochloride was administered simultaneously with radiation. The tumour volume was 1.2 ctn', a percentage reduction of 76% (Figure 3 ).
Hyperthemia. The tumour volume of untrr:ated control mice was 4.3cm3 at day 30 which was reduced to 3.43 cm3 after hyperthermia treatment. In mice treated with berberine hydrochlorid-the tumour volume was reduced to 1.74cm3. The r:ffect of berberine hydrochloride was synergist.cally increased by hyperthermia and tumour vc,lume was significantly reduced to 0.93cm3 (Figul-e 3), a percentage reduction of 78%.
Discussion
The antitumour activity of berberine has been reported in myelocytic leukaemic HL60 cells where it induced differentiation and apoptotic death.
In this study, using DLA cells, the antiturnour activity was significant only when the dm;: was given intraperitoneally. Oral administration of berberine did not produce any change in the growth of ascites tumour whereas solid tissue growth was significantly inhibited.
Rerherine synergistically reduced solid t~aanotar volume when combined with radiation, cyclophos-(?hi~mitlc :an11 hypcrlhcrn,i:~. Iicncc hcrhcl-inc coulcl be of use in the treatment of cancer as a response n~odilier ol' olhcr trc;ltrncnts.
As yet we do not know the mechanism of action of berberine. Initial studies indicate that berberinc inhibits bacterial topoisomerase activity. Similarly, berberine inhibited cdc25 hosphatase activity in-P .
vitro (IC50 I 5 0~g mL-) whtle cdc2 kinase activity was not inhibited. This indicates that the activity of bcrkrinc may bc partially due to thc inhibition of cell cycle arrest which may produce apoptic death. Berberine, an alkaloid iso ated from the plant Berberis aristata, has been found to inhibit significantly the carcinogenesis induced by 20-methylcholanthrene (200 ygM.1 mUmouse) or N-nitrosodiethylamine (NCEA; 0.02 % NDEA in distilled water, 2.5 muanimal by gavage, five days a week for 20 weeks1 in a dose-dependent manner in small animals. Administration of berberine (0.5.2.5 or 5.0 mg kg-') could reduce significantly the incidence of tumour in animals after an injection of 20-me?thylcholanthrene and increased their life span compared with the control. When berberine (10.25 or 50 mg kg-') was administered simultaneously with NDEA. the markers of liver injuty (liver weight, y-glutamyl transpeptidase activity and glutathione Stransferase level) were reduced significantly compared with animals treated with NDEA only, which resulted in all thevalues being elevated. Asimilardecrease was noted in theserum levels of lipid peroxide, bilirubir~ and glutamate pyruvate transaminase. Morphology of liver tissue and levels of marker enz!,mes indicated that berberine offered protection against chemical carcinogenesis.
Hepatocellular carcinoma is widely prevalent in some areas of the Far East and in Africa. The causative agents are reported to be hepatitis B virus and environmental pollutants, of which nitrosoamines have a major role. N-Nitrosodiethylamine (NDEA), a potent hepatocarcinogen, is a byproduct of the nitrosation of primary amines in the acidic condition of the stomach, and is present in many food products e.g. meat, beer etc. NDEA has been shown to be metabolized to its active ethyl radical metabolite (C:H,CHZt) and the reactive product interacts with DNA producing mutation and further oncogenesis. Similar activation is also involved in the carcinogenic action of polyaromatic hydrocarbons.
Berberine, an isoc{uinoline alkaloid, has been reported to have multiple pharmacological acti.>ns (Ckless et al 1995) . Antitumour activity of berberine against human and rz t malignant brain tumour celis has been reported (Zhank et a1 1990) . Recently, u e reported that berberine could potentiate the antitumour activity of cyclophos~~hamide and radiation in animals (Anis et al 1999) . Chang et al (1990) showed that berberine was able to down-regulate c-ki-ras 2 oncogene expression in human teratocarcinoma cells, indicating that berberine may be able to inhibit the proliferatisn of cancer cells produced by chemical carcinogens. In this study we have invest-gated the chemopreventive activity of berberine against 20-methylcholanthrene-induced sarcoma in mice and NDEA-induced hepatocarcinogcnesis in rats.
Materials and M d h d
Animals Fifty female Wistar rats (120-1 50 g) were obtained from the Vetertnary College, Mannuthy, India. They were housed in ventilated cages and fed with a pelleted diet (Lipton, India Ltd) with water freely available. The male Swiss albino mlce (20-25 g) used were reared in our facility.
Materials
Berberine hydrochloride was a gift from Dr Rajpal, Kisalaya Herbals Ltd. (Indore, India). 20-Methylcholanthrene was purchased from ICN-Pharmaceuticals (New York, NY). N-Nitrosodiethylamine (NDEA) was obtained from Sigma Chemicals (St Louis, MO). I-Chloro-2, 4-dinitrobenzene, glutathione, and 5.5-dithiobis(2-nitrobenzoic acid) were purchased from Sisco Research Laboratory (Bombay, India). Thiobarbituric acid was obtained from E-Merck (Germany). All other chemicals used were of analytical reagent grade.
Drug preparation
Desired concentrations of berberine hydrochloride were dissolved in hot water and administered orally to the animals.
Determination of the effect of brrberine hydrochloride on 20-methykhd~threne-induced sarcoma Swiss albino mice (2&25 g, 15/group) were used for the study. Hair was removed from the dorsal side of all animals and a single dose of 20-methylcholanthrene (200 pg/O. I mL/mouse) wasinjected subcutaneously on the dorsal side. The animals were divided into four groups. Group I , which rcceived 20-methylcholanthrene only, was kept as a positive control. Groups 2, 3 and 4 received 20-methylcholanthrene and different concentrations (5. 2.5 and 0.5 mg kg-]) of berberine hydrochloride, respectively. Thisdosage, which was non-toxic to the animals, was selected after determining the LD50 of berberine in the animals (results not shown). Administration of the drug started five days before 20-methylcholanthrene injection and continued for eight weeks, thrice a week orally. The control group was kept without any treatment. The animals were observed for the onset of sarcoma as well as for their survival up to 180 days.
Determination of the effect of berberine hydrochloride on NDEA-induced hepatocarcinogenesis Liver tumours were induced by the administration of NDEA as described by Narurkar & Namrkar (1989) with slight modifications. Six-week-old female Wistar rats (120-125 g) were divided into five groups (10 animals/group). Group 1 served as untreated normal animals. Group 2 received 0.02% NDEA in distilled water, 2.5 mL/animal by gavage, five days a week for 20 weeks. This dosage was found to induce liver tumours in the rats (Jose Jeena et a1 1999) and animals died by 29-31 weeks. Groups 3 , 4 and 5 were administered 50, 25 and 10 mg kg-' berberine hydrochloride, respectively, along with NDEA. This dosage was found to be nontoxic to rats. Berberine hydrochloride was administered 24 h before the first dose of NDEA and was continued for 20 weeks. Animals were kept without any treatment for a further 10 weeks before being killed. At the end of the 30fi week animals were administered diethylether anaesthesia, and blood and liver tissues were collected immediately. Change in liver weight and tumour incidence produced by NDEA treatment was noted. Serum was separated and part of the tissue was fixed in formalin and the rest were kept frozen until analysed.
The following serum and liver parameters were measured to assess the effect of berberine hydrochloride on bepatocarcinogenesis. Serum levels of y-glutamyl transpeptidase activity were measured by Szasz's method using an AVT diagnostics kit (Szaz 1976 ) and tissue y-glutamyl transpeptidase was measured using yglutamyl p-nitroanilide as substrate (Tate & Meister 1974) . Cytosolic glutathione S-transferase activity was determined by its ability to conjugate glutathione with I-chloro-2,4-dinitrobenzene (Habig et a1 1974) . Tissue levels of reduced glutathione were determined by its reaction with 5,5-dithiobis(2-nitrobenzoic acid) (Moron et al 1979) . Lipid peroxidation in serum was estimated by the thiobarbituric acid method (Ohkawa 1979) . Protein was analysed by the method of Lowry et a1 (1951) . Glutamate pyruvate transaminase activity was measured in serum (Bergmeyer & Bernt 1980) . Serum total bilirubin level was estimated by the method of Jendrassic & Grof (1938) .
Statistical analysis
Results were expressed as mean f s.d. and evaluated by Student's t-test. Berberine hydrochloride could inh~bit sarcoma development induced bq 20-methylcholanthrene in a dosedependent manner. Oral administration of the drug (5, 2.5 or 0.5 mg k g ' ) was found t i ) Inhibit sarcoma development by 60 fY~l. 5 3 and 3 3 U';,. respectively ( Figure  I ). Animals treated with berber~ne and 20-methylcholanthrene werc shown to habe an increased life span (Tablc I). Control :tnimals hcgal~ dying of tumour burden after 80 days of carcinogen treatment, with all the animals dying by 180 days. whereas in the treated groups only 6. 7 and 10 animals. respectively, had died hv I80 ,lays.
'The eflect oC herbel-I~L. Iiyd~,icllloride on NDEAInduced liver tnmour incidence is shown in Table 2 . The NDEA-treated group showed 100 % tumour incidence hy tlrc end of the iOlh wech i\hcreas the herberinetreated groups showed a dosc-dcpcndent reduction of tumoi~r inc~dcncc. Iiihih~tio~~ 01 lulnour incidence was also reflected in changes in livc~ ueights. Liver weight of norm;~l ;unimals wah hhown to he 2.7 f 0.2g/l00 g, which was significantly increased by NDEA treatment to 8.9k2.1 g/lOO g ( P < 0.001). Liver weight of the berberine-treated groups was found to be reduced significantly in a dose-dependent manner.
y-Glutamyl transpeptidase enzyme activity, a nonspecific marker of liver neoplasm, was significantly elevated from 30.4k5.8 to 152k37 U L-' in serum and from 0.01 k0.002 to 0.15f 0.02 nmol min-' (mg protein)-' in liver by the administration of NDEA. Administration of berberine (10,25 or 50 mg kg-') reduced the serum y-glutamyl transpeptidase levels to 119, 93 and 82 U L-', respectively. Liver y-glutamyl transpeptidase levels were also significantly ( P < 0.001) reduced by the administration of berberine hydrochloride (Table 3) .
NDEA-treated groups showed significantly elevated liver glutathione S-transferase activity (1769k898) compared with the normal group (377k 13; Table 4 ), which may bedue to induced dctoxific;~tion mechanisms for elimination of NDEA and its metabolites. A dosedependent decrease in glutathione S-trensferilse level (837 +605 to 549f 128 nmol min-I (mg protein)-') was observed in the berberine-treated group (10-50 mg Table 4 Ellect oC berberjnc on livcr glutiuhionc S-lr,inslcr;csc and glutathione levels in rats irrated with N-nitrosodicthylamine (NDEA). kg-'). Reduced glutathione activity was also elevat:d by These were elevated to 3.0i0.67 nmol mL-I and the administration ofNDEA. However, berberine .reat-5892 168 U mL", respectively, after the administration mcnt had only ;I marginnl elTect on gluvathione levels of NDEA. Sin~ult;~neous administration of berberine (Table 4) .
Group
significantly lowered the lipid peroxide and glutamateLipid peroxide and glutamate-pyruvate transan-inase pyruvate transaminase level in adose-dependent manner levels in normal rat serum were found t, be (Table 5) . Similarly, serum bilirubin, which is a bio-1.3 k0.25 nmol m L 1 a n d 170+ 52 UmL-I, respectively. marker for liver damage, was significantly (P i 0.01) lnhib~tlon of chem~cal carcinogenesis by berberine increased by the NDEA treatment. In the animals treated with berberine. bilirubin levels were almost equal to normal values (7';tble 5).
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